Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Vitamin D in Tuberculosis Treatment (AdjuVIT)
2005-003562-42Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary tuberculosis (TB) comparing Standard antituberculous therapy + vitamin D with Standard antituberculous therapy + placebo (2 arms). Primary endpoint: Time to sputum culture conversion. Started Jan 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on 2005-003562-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003562-42.